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Genetic deletion of the Pten tumor suppressor gene promotes
cell motility by activation of Rac1 and Cdc42 GTPases
Joanna Liliental*†, Sun Young Moon‡, Ralf Lesche*§, Ramanaiah Mamillapalli¶,
Daming Li¶, Yi Zheng‡, Hong Sun¶ and Hong Wu*§
Pten (Phosphatase and tensin homolog deleted on
chromosome 10) is a recently identified tumor
suppressor gene which is deleted or mutated in a
variety of primary human cancers and in three cancer
predisposition syndromes [1]. Pten regulates
apoptosis and cell cycle progression through its
phosphatase activity on phosphatidylinositol (PI)
3,4,5-trisphosphate (PI(3,4,5)P3), a product of PI
3-kinase [2–5]. Pten has also been implicated in
controlling cell migration [6], but the exact mechanism
is not very clear. Using the isogenic Pten+/+ and
Pten–/– mouse fibroblast lines, here we show that Pten
deficiency led to increased cell motility. Reintroducing
the wild-type Pten, but not the catalytically inactive
Pten C124S or lipid-phosphatase-deficient Pten G129E
mutant, reduced the enhanced cell motility of Pten-
deficient cells. Moreover, phosphorylation of the focal
adhesion kinase p125FAK was not changed in Pten–/–
cells. Instead, significant increases in the endogenous
activities of Rac1 and Cdc42, two small GTPases
involved in regulating the actin cytoskeleton [7], were
observed in Pten–/– cells. Overexpression of dominant-
negative mutant forms of Rac1 and Cdc42 reversed the
cell migration phenotype of Pten–/– cells. Thus, our
studies suggest that Pten negatively controls cell
motility through its lipid phosphatase activity by
down-regulating Rac1 and Cdc42.
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Results and discussion 
To test the role of Pten in cell migration, we established
independent immortalized fibroblast lines from wild-type
and Pten deficient (Pten–/–) mice, using the 3T9 protocol [8].
Similar to primary mouse embryonic fibroblasts [4], the
immortalized Pten–/– cell lines showed increased levels of
phosphorylation of protein kinase B/Akt compared to their
wild-type counterparts and were resistant to serum-depriva-
tion induced apoptosis. In contrast to our observation with
wild-type and Pten–/– embryonic stem cells [4], however, no
significant differences in the rates of cell proliferation and
the levels of the cyclin-dependent kinase inhibitor p27KIP1
could be detected between log-phase growing wild-type
and Pten–/– fibroblast cells (data not shown).
Pten–/– fibroblasts have an increased cell motility, as shown
by a classic ‘wound healing’ assay (Figure 1a, left panels)
[9]. They were able to completely close the wound within
15 hours, whereas wild-type cells took almost 30 hours. To
demonstrate that the increase in cell migration is an indi-
vidual cell based and cell division-independent event, we
employed a colloidal-gold based motility assay [10]. This
assay revealed that Pten–/– fibroblasts could produce longer
‘trails’ than wild-type cells in a defined time period, indi-
cating that Pten–/– cells indeed migrate faster than the
wild-type cells (Figure 1a, middle panels). In order to
obtain more quantitative measurements of the migration
distance, we employed a modified ‘wound healing’ assay.
In this assay, cells are first seeded on coverslips, and then
transferred to a new plate coated with fibronectin. Upon
transfer, cells migrate from the rim of the coverslip out-
wards onto the new plate. As shown in Figure 1a (right
panels) and quantified in Figure 1b with independent cell
lines, Pten–/– cells migrate almost twice as fast as wild-type
cells. Moreover, careful observation of cell morphology
revealed that Pten–/– fibroblasts appeared rounded and had
intense cortical F-actin staining (Figure 1c). Together,
these results suggest that Pten negatively regulates signal-
ing pathways controlling cell migration. 
In order to determine whether increased cell migration in
Pten–/– cells is due to lack of the Pten phosphatase activity
or if other structural motifs may play a role, we re-intro-
duced either wild-type Pten or Pten C124S, a catalytically
inactive mutant, into the Pten–/– cells by retrovirus infec-
tion [11]. We used a retroviral vector that expresses the
gene of interest and the green fluorescent protein (GFP)
as a bicistronic mRNA. GFP-positive, thus Pten-express-
ing, cells were sorted by fluorescence activated cell sorting
(FACS) following retroviral infection. Wild-type Pten and
the C124S mutant were expressed in comparable levels in
the sorted populations (Figure 2c). As shown in Figure 2a
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and quantified in Figure 2b, wild-type Pten, but not the
C124S mutant, could fully reverse the migration pheno-
type of Pten–/– cells, confirming that the enhanced motility
is directly due to the lack of Pten phosphatase activity. 
Recent studies suggested that PI(3,4,5)P3 is a major sub-
strate for Pten both in vitro [2] and in vivo [3,4]. Interest-
ingly, Pten G129E is deficient for the phosphatase activity
towards PI(3,4,5)P3, while its activity towards synthetic
protein substrates is unaffected [12]. Using the Pten
G129E mutant, we further tested whether Pten controls
cell migration through its lipid phosphatase activity or its
protein phosphatase activities. Pten G129E behaved simi-
larly to the C124S mutant as they were both unable to
rescue the migration phenotype in this assay. This experi-
ment suggests that the enhanced motility of Pten–/– cells is
a result of the loss of Pten phosphatase activity, in particu-
lar, its lipid-phosphatase activity. 
It has been suggested that Pten negatively regulates cell
migration by directly dephosphorylating p125FAK and
changing mitogen-activated protein (MAP) kinase activity
[6,13]. In order to test whether p125FAK phosphorylation
and MAP kinase activation are also affected by the loss of
Pten, we examined the tyrosine phosphorylation status of
these proteins. Whole cell lysates from log-phase growing
wild-type or Pten–/– fibroblasts were immunoprecipitated
with 4G10 anti-phosphotyrosine antibody and western
blotted with anti-FAK antibody (Figure 3a, upper panel), or
were immunoprecipitated with anti-FAK antibody and
western blotted with 4G10 (Figure 3b, lower panel). In con-
trast to what would be predicted if Pten could directly
dephosphorylate p125FAK, no difference in tyrosine phos-
phorylation of p125FAK could be detected in Pten–/– fibro-
blast lines compared to wild-type cells. The activation status
of MAP kinases was not affected by the Pten deletion either,
but the level of Akt phosphorylation was significantly
increased in Pten–/– fibroblast cell lines (data not shown),
similar to what we have observed previously in Pten–/–
embryonic stem cells [4]. These results suggest that the
enhanced cell motility caused by Pten deficiency may be
mediated by effectors other than p125FAK and MAP kinases.
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Figure 1
Pten-deficient fibroblasts migrate faster than wild type. (a) An equal
number of wild-type (WT) or Pten–/– fibroblasts were seeded on a
fibronectin-coated plate and cultured for 24 h. Migration into the
wound is shown 15 h after the wound was introduced (left panels;
open arrowheads point to the boundaries of the wound at time = 0).
In the middle panel, 2 × 103 cells per well were seeded on colloidal
gold-coated 6-well dishes in duplicates. Migration of wild-type or
Pten–/– fibroblasts is shown at 24 h. The scale bar represents 10 µm.
In the right panels, wild-type or Pten–/– fibroblasts grown on glass
coverslips were placed onto 5 µg/ml fibronectin-coated dishes and
cultured for 15 h. (b) Cell motility was assessed and compared using
independent cell lines. Migration distances were determined by taking
seven independent measurements from each coverslip. Each
experiment was conducted in triplicate, and mean ± SD was
calculated. The migration distance is normalized so that 100%
represents migration distance of Pten–/– cells. (c) Pten–/– cells
exhibited increased cortical actin polymerization as compared to the
wild-type cells. Briefly, log-phase growing fibroblasts were cultured
without serum for 20 h. After fixation in 4% paraformaldehyde, cells
were permeabilized with 0.2% Triton X-100 and stained for F-actin
using rhodamine–phalloidin (Molecular Probes). 
Figure 2
Increased cell motility in Pten–/– cells is due to the lack of lipid
phosphatase activity of Pten. (a) Pten–/– cells were infected with
retroviral GFP vectors containing wild-type Pten (WT), G129E (GE), or
C124S (CS) Pten mutants. Control wild-type or Pten–/– cells were
infected with viruses containing GFP only. 48 h later, GFP positive
cells were sorted by fluorescence-activated cell sorting (FACS),
seeded onto glass coverslips in triplicate, and grown for an additional
5 h. Cells on coverslips were then replaced onto a fibronectin-coated
surface and incubated for 15 h. (b) Quantitative representation of (a).
Cell migration is normalized so that 100% represents the migration
distance of Pten–/– cells infected by empty vector. (c) Pten protein
levels in uninfected and infected cells after FACS sorting. Western
blots of total protein extracts were probed with an affinity-purified anti-
Pten antibody. Blots were reprobed with anti-FAK antibody (Santa
Cruz Biotechnology) to confirm equal loading.
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As increased cell motility is associated with a deficiency in
Pten lipid-phosphatase activity, and cells in which Pten is
genetically deleted contain elevated levels of PI(3,4,5)P3
[3,4], we next examined whether activation of known
downstream PI(3,4,5)P3 effectors might be responsible for
the increased cell migration phenotype in Pten–/– cells.
Activation of Cdc42 and Rac1 has been implicated in pro-
moting cell migration [7] and their GDP/GTP exchange
factors (GEFs) can be activated in a PI(3,4,5)P3-depen-
dent manner [14,15]. We therefore examined whether
Pten deficiency leads to changes in the Rac1 and Cdc42
activities. In this assay, the p21-binding domain of PAK1
was expressed as a GST-fusion protein. GST–PAK1 can
specifically recognize Rac1–GTP or Cdc42–GTP forms,
but not GDP-bound forms, suggesting that the affinity
precipitation assay is specific and effective in assessing the
activation states of Rac1 and Cdc42 (Figure 3b). We then
examined the level of endogenous GTP-bound forms of
Rac1 or Cdc42 in Pten–/– cells and wild-type cells. As
shown in Figure 3c, there are marked increases of the
GTP-bound forms of Rac1 and Cdc42 in logarithmically
growing Pten–/– cells compared to wild-type cells, although
the total protein levels are not affected by the Pten status.
As PI(3,4,5)P3 levels were highly sensitive to growth con-
ditions [4], we also examined the Rac1 and Cdc42 activi-
ties in unfavorable confluent culture conditions. There is a
notable ~30% increase in Rac1–GTP content and a ~50%
increase in Cdc42–GTP content compared to the wild-
type cells (Figure 3d). When similar assays were per-
formed using suspended cell cultures which lack the
adherent stimuli, ~60% and ~130% increases of
Rac1–GTP and Cdc42–GTP forms, respectively, were
observed (Figure 3d, suspension). The extent of elevation
in the endogenous Cdc42 and Rac1 activities in Pten–/–
cells were consistent when independent cell lines were
used, and reintroducing wild-type Pten into Pten–/– cells
led to a decrease in the GTP-bound forms of Rac1 and
Cdc42 (data not shown). 
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Figure 3
Pten deletion results in activation of Rac1 and Cdc42, but not FAK.
(a) FAK phosphorylation is not affected by Pten deletion. Upper panel,
equal amounts of proteins were immunoprecipitated with
anti-phosphotyrosine antibody (4G10, Upstate Biotechnology).
Western blots were probed with anti-FAK antibody. Bottom panel,
anti-FAK immunoprecipitates were western blotted with 4G10 (for
phosphorylated FAK, FAK–P) or an anti-FAK antibody. rIgG indicates
immunoprecipitation with a rabbit isotype control antibody.
(b) GST–PAK binding is specific for GTP. Pten–/– fibroblast lysates
were loaded with GTPγS or GDP prior to affinity precipitation with
GST or GST–PAK immobilized on 10 µg glutathione–agarose beads.
The precipitated proteins were analyzed by western blot with anti-
Rac1 (Upstate Biotechnology) or anti-Cdc42 (Santa Cruz
Biotechnology) antibody, respectively. Results are representative of
three independent experiments. (c) The GST–PAK precipitates from
wild-type (+) and Pten–/– (–) fibroblasts under log phase growing
conditions, along with total cell lysates, were analyzed by western blot
with anti-Rac1 or anti-Cdc42 antibodies. (d) Wild-type or Pten–/–
cells, either in suspension or adherent, were lysed and subjected to
GST–PAK affinity precipitation analysis. The Rac1–GTP (upper graph)
or Cdc42–GTP (lower graph) activities detected by western blot were
normalized to the amount of Rac1 or Cdc42 in whole cell lysates.
Results are means ± SD from three experiments. (e) Pten–/– cells
were treated with 20 µM LY294002 (shown here, +), or 50 nM
wortmannin (not shown), or DMSO vehicle control (–) for 6 h before
harvesting. Cell lysates were precipitated with GST–PAK and blotted
with anti-Rac1 or anti-Cdc42 antibodies, respectively. In parallel,
aliquots of cell lysates were analyzed with anti-phospho-Akt antibody
(New England Biolabs). 
Figure 4
Increased motility of Pten–/– cells can be reversed by expression of
dominant-negative (DN) Rac1 and Cdc42, but not RhoA. Cell motility
was assessed by directly measuring the migration distance 15 h after
plating, and presented as an average of three independent
experiments. WT, wild-type constructs were expressed; GFP, a GFP-
expressing vector only was expressed.
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Recent experiments demonstrated that a correlation exists
between activation of the activity of PI 3-kinase and the
activities of Rac1 and Cdc42 [14–17]. However, whether
PI 3-kinase functions downstream or upstream of Rac1
and Cdc42 remains unclear. To test whether Rac1 and
Cdc42 were activated in a PI 3-kinase dependent manner,
we treated Pten–/– cells with the PI 3-kinase inhibitor
LY294002 or wortmannin. Figure 3e shows that the activi-
ties of Rac1 and Cdc42 dramatically decrease upon treat-
ment with PI 3-kinase inhibitors, indicating that similar to
Akt, Rac1 and Cdc42 activation in Pten–/– cells is down-
stream of PI 3-kinase. 
To formally prove that the elevated endogenous activities
of Rac1 and Cdc42 in Pten–/– cells are responsible for the
increased cell migration phenotype, we introduced either
wild-type or dominant negative forms of Rac1 (N17Rac1)
and Cdc42 (N17Cdc42) into Pten–/– cells by retroviral infec-
tion. These mutants are thought to act by sequestering
specific GEFs necessary for activation of Rac1 and Cdc42,
preventing their functions. Figure 4 shows that expression
of N17Rac1 and N17Cdc42 in Pten–/– cells could reverse
the cell migration phenotype by 100% and 50%, respec-
tively. The less efficient reversion by N17Cdc42 is not due
to the lower expression level (data not shown), but could
reflect the suggested hierarchical relationship between
Rac1 and Cdc42, where Cdc42 is thought to function
upstream of Rac1 [7]. As a control for the specificity of
these GTPases, we also expressed the dominant negative
form of RhoA (N19RhoA), a GTPase involved in focal
adhesion and stress fiber formation [18,19]. No effect on
the migration of Pten–/– fibroblasts was observed with
N19RhoA, or with the wild-type Rho GTPases (Figure 4).
These results indicate that Rac1 and Cdc42 serve as down-
stream effectors of Pten in the regulation of cell migration.
In summary, we show that inactivation of the Pten tumor
suppressor gene promotes cell motility in fibroblasts. In
contrast to previous reports that Pten negatively regulates
cell migration by directly dephosphorylating p125FAK and
changing MAP kinase activities, we demonstrate geneti-
cally that the tumor suppressor Pten controls cell motility
by down regulating Rac1 and Cdc42 GTPases, and this
negative regulation is dependent on the lipid phosphatase
activity of Pten. In combination with our previous work
and other studies, we suggest that Pten exerts its tumor
suppressor function not only at the stage of tumor initia-
tion, but also in tumor progression and metastasis.
Supplementary material
Supplementary material including additional methodological details is
available at http://current-biology.com/supmat/supmatin.htm.
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